1. Home
  2. MDCX vs CPIX Comparison

MDCX vs CPIX Comparison

Compare MDCX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.50

Market Cap

26.2M

Sector

N/A

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$2.83

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDCX
CPIX
Founded
2008
1999
Country
United States
United States
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
73.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
MDCX
CPIX
Price
$0.50
$2.83
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
8.2M
127.3K
Earning Date
03-27-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$0.37
$1.85
52 Week High
$8.90
$6.27

Technical Indicators

Market Signals
Indicator
MDCX
CPIX
Relative Strength Index (RSI) 31.88 30.93
Support Level $0.37 $2.78
Resistance Level $1.43 $3.80
Average True Range (ATR) 0.13 0.29
MACD -0.02 -0.08
Stochastic Oscillator 9.53 6.40

Price Performance

Historical Comparison
MDCX
CPIX

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: